Prediction of prostate cancer by deep learning with multilayer artificial neural network.
暂无分享,去创建一个
Takumi Takeuchi | K. Mikami | T. Takeuchi | Koji Mikami | Mami Hattori-Kato | Yumiko Okuno | Satoshi Iwai | Mami Hattori-Kato | Y. Okuno | S. Iwai
[1] Osamu Ukimura,et al. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. , 2016, European urology.
[2] W. Ellis,et al. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. , 2013, European urology.
[3] M. Barry,et al. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. , 2007, Journal of the National Cancer Institute.
[4] M. Kattan,et al. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice. , 2008, The Journal of urology.
[5] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[6] A. Haese*,et al. Development and external validation of an extended repeat biopsy nomogram. , 2007, The Journal of urology.
[7] M. Kattan,et al. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information. , 2011, Urology.
[8] G. Haber,et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.
[9] M. Melissari,et al. A novel nomogram to predict the probability of prostate cancer on repeat biopsy. , 2008, The Journal of urology.
[10] A. Rosenkrantz,et al. Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings. , 2017, Urology.
[11] M. Kattan,et al. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. , 2009, The Journal of urology.
[12] J. Fütterer,et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.
[13] R. Faletti,et al. Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer. , 2017, European urology.